VULCUR MEDTECH

TREATING CHRONIC WOUNDS

Vulcur MedTech is a medical device development company focusing on wound healing, using our VMT (VulCur MedTech) laser.

A PAINFUL CONDITION


Chronic wounds are defined as wounds which refuse to heal within a period of 3 months. At this stage wounds are no longer able to heal by themselves or may take years to do so.


Available types of treatment have not changed over the past 50 years. The old fashioned techniques such as dressing application and wound cleansing only target the top layer of the wound. They fail to target the in depth bacterial biofilm which is present in and around chronic wounds.

NEW TREATMENT METHOD


Research has shown the existence of biofilm producing bacteria within the tissue in and around chronic wounds. These bacteria show a great resistance to antibiotics and secrete inflammatory antigrowth factors which stall the healing process. It is believed that all chronic wounds are infected with this biofilm producing bacteria.


Our VMT method of treatment uses laser pulses which penetrate inside the tissues ablating the bacteria without damaging the human cells. This helps aid the body’s natural healing process.


The VMT method makes healing of otherwise untreatable chronic wounds possible. It also reduces the time to heal while increasing patients’ quality of life.

OUR SUPPORTERS

READ ABOUT US

MEET THE TEAM

Board of directors



Janus Beierholm


CEO and Founder

janus.larsen@gmail.com

Simon Gabriel


BBA and CEO at Gabriel Consulting

Magnus Ågren

 

Professor at Bispebjerg Hospital

Claus Rehfeld


MBA and Partner at H2I

Advisory board

Bettina Grote


Senior R&D Engineer at Novo Nordisk

Jakob Poulsen

 

CEO at VALUA, European Patent Attorney

Emil Jacobsen


Software engineering, CTO at EyeJustRead

Sebastian Rungby


 Juniorpartner, advokat / Associate Partner, attorney at law at Lund Elmer Sandager

Claus Rømer Andersen

 

EMC & Radio Consultant for Medical Devices

email: kontakt@vulcurmedtech.com